Natus Medical Incorporated recently announced that it priced an offering to sell 2.3 Million shares of its common stock at a price of $11.63 per share. The shares are being sold under the Company's previously filed shelf registration statement, which was declared effective by the Securities and Exchange Commission on August 15, 2006.

The Company expected that the net proceeds of the offering will be approximately $25 million after deducting underwriting commissions and discounts and other expenses associated with the offering. The Company currently intends to use the proceeds for general corporate purposes, which may include the financing of potential acquisitions of, or investments in, companies and technologies that complement the Company's business, as well as for capital expenditures and working capital needs. The Company may also use a portion of the proceeds to repay some or all of the remaining balance on its senior secured credit facility with Wells Fargo Bank.

Roth Capital Partners, LLC acted as the sole underwriter of the offering.